Your browser doesn't support javascript.
loading
Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss.
Popov, Violeta B; Lim, Joseph K.
Afiliação
  • Popov VB; Division of Gastroenterology, New York University School of Medicine, New York, NY, USA.
  • Lim JK; Yale Liver Center, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, USA.
J Clin Transl Hepatol ; 3(3): 230-8, 2015 Sep 28.
Article em En | MEDLINE | ID: mdl-26623270
Nonalcoholic fatty liver disease (NAFLD) represents a rapidly growing cause of chronic liver disease in the United States and is associated with significant morbidity and mortality, including progression to liver cirrhosis and hepatocellular carcinoma. NAFLD comprises a spectrum of liver conditions, ranging from simple steatosis to steatosis with inflammation (steatohepatitis) and progressive fibrosis. Weight loss represents a first line therapeutic modality for the management of NAFLD. Herein, we review the evidence base for medical, surgical, and endoscopic approaches to weight loss and their potential impact on the natural history of NAFLD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Transl Hepatol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Transl Hepatol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos